- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease
Total 10000 results
-
Shu WangRecruitingHER2-positive Breast CancerChina
-
Ahmad ShariftabriziProgenics Pharmaceuticals, Inc.Recruiting
-
Federal University of AlagoasRecruitingExercise | Breast Cancer FemaleBrazil
-
Saglik Bilimleri UniversitesiNot yet recruiting
-
Juravinski Cancer CenterJuravinski Cancer Centre FoundationNot yet recruitingMetastatic Breast Cancer | Oligoprogression
-
Hebei Medical University Fourth HospitalRecruitingBreast Cancer | HER2-negative Breast CancerChina
-
Fudan UniversityRecruitingHER2-positive Breast CancerChina
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; Swim Across AmericaRecruitingBreast Cancer | Cancer of the BreastUnited States
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingBreast Cancer | HER2-low Breast CancerChina
-
M.D. Anderson Cancer CenterArtidisRecruitingBreast Carcinoma | Invasive Breast CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Private Philanthropic FundsRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteVaccinex Inc.RecruitingHER2-positive Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Beijing Huanxing Cancer Hospital; Cancer Hospital, Chinese Academy of Medical...RecruitingEarly-stage Breast CancerChina
-
Xijing HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Breast Cancer
-
German Cancer Research CenterRecruitingEarly-stage Breast CancerGermany
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHER2-positive Breast Cancer
-
Gadjah Mada UniversityAhmad Dahlan University; Dr. Kariadi General Hospital; PT Konimex; LPDP, Kementerian...RecruitingBreast Cancer Stage IVIndonesia
-
The First Affiliated Hospital with Nanjing Medical...RecruitingHER2-negative Breast CancerChina
-
Henan Cancer HospitalRecruitingBreast Cancer,HER2-positiveChina
-
University of MiamiRecruitingBreast Cancer | Early-stage Breast CancerUnited States
-
Henrik LindmanRoche Pharma AG; Swedish Breast Cancer Group; Swedish Cancer Society; AffibodyRecruitingHER2-positive Breast CancerSweden
-
Qamar KhanRecruitingHER2-positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCActive, not recruiting
-
Dartmouth-Hitchcock Medical CenterActive, not recruitingBreast Cancer | ER Positive Breast CancerUnited States
-
SOLTI Breast Cancer Research GroupNovartis; UNICANCERActive, not recruitingBreast Cancer Stage IISpain, France, Portugal
-
University of WashingtonTerminatedHER2-positive Breast CancerUnited States
-
Seagen, a wholly owned subsidiary of PfizerMerck Sharp & Dohme LLCActive, not recruitingHER2 Positive Breast CancerUnited States, Netherlands, China, Brazil, Canada, France, Australia, Spain, Belgium, Czechia, Japan, United Kingdom, Taiwan, Finland, Germany, Italy, Poland, Portugal, Austria, Chile, Greece, Switzerland, South Korea
-
Novartis PharmaceuticalsActive, not recruitingAdvanced HER2+Breast CancerUnited States, Belgium, China, France, Malaysia, Spain, Italy
-
Medical College of WisconsinCompletedNode Positive Breast CancerUnited States
-
Hoffmann-La RocheActive, not recruitingBreast CancerUnited States, Israel, Peru, Spain, Italy, Germany, Czechia, South Africa, Mexico, Taiwan, Australia, Brazil, Poland, Hungary, South Korea, Argentina
-
Richard ZellarsActive, not recruitingBreast Cancer | Adenocarcinoma of the BreastUnited States
-
AstraZenecaCompletedAdvanced Metastatic Breast CancerUnited States
-
University of Alabama at BirminghamWithdrawnHER2-positive Breast CancerUnited States
-
The Christie NHS Foundation TrustUniversity of ManchesterWithdrawn
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruiting
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Active, not recruiting
-
AstraZenecaCompletedBreast Cancer | Breast Neoplasms | Breast Carcinoma | Genes | HER2United Arab Emirates, Saudi Arabia, Qatar, Kuwait
-
Breast Cancer Trials, Australia and New ZealandETOP IBCSG Partners Foundation; Breast International GroupActive, not recruitingEarly Stage Breast CarcinomaSpain, Taiwan, Ireland, Australia, Argentina, Italy, New Zealand, Switzerland, Chile
-
Beni-Suef UniversityCompletedTriple -Negative Breast CancerEgypt
-
Xinhong Wu, PhDActive, not recruiting
-
Daiichi SankyoCompletedHER2-positive Breast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Austrian Breast & Colorectal Cancer Study...Active, not recruitingNeoplasms | Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Carcinoma | BRCA1 MutationUnited States
-
University of MalayaNational University Hospital, Singapore; Merck Sharp & Dohme LLC; Cancer Research...Active, not recruitingHER2-Negative Breast CancerSingapore, Malaysia
-
West German Study GroupTeva Pharmaceuticals USACompletedEarly Primary Breast CancerGermany
-
AstraZenecaCompletedHER2-negative Breast CancerMexico, United Kingdom, Georgia
-
European Institute of OncologyActive, not recruitingEarly Stage Breast CarcinomaItaly, Chile, Spain, Switzerland